BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that president and chief executive officer Francois Nader, M.D. has been appointed to the Biotechnology Industry Organization’s (BIO’s) Board of Directors as a member of the Health Section Governing Board.
Help employers find you! Check out all the jobs and post your resume.
